|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cytotoxic drug sensitivity testingof tumor cells from patients with ovarian carcinoma using the fluorometri microcuhure cytotoxicity assay ( FMCA ) 显示文摘 | Csoka K Larsson R Tholander B | 1994 | Gynecol Oncol1994，54，2： | 1 |
| 2 | Pretreatment serum levels of CA 125, earcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma:Influence of histological type,grade of differentia- tion, and clinical stage of disease显示文摘 | Tholander B Taiube A Lindgren A | 1990 | Gynecol Oncol1990，39，1： | 1 |
| 3 | Pharmacokinetics Of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anes- thetized dogs 显示文摘 | Ericsson H Tholander B Bjrkman JA | 1999 | Drug Metabol Disposit1999，27，5： | 1 |
| 4 | Pharma- cokineties of new calcium channel antagonist clevidip- ine in the rat, rabbit, and dog and pharmacokinetic / pharmacodynamic relationship in anesthetized dog显示文摘 | Ericsson H Tholander B BjSrkman JA | 1999 | Drug Metab Dispos1999，27，7： | 1 |
| 5 | Pretreatment serum levels of CA-125,carcinoembryonic antigen,tissue polypeptide antigen,and placental al-kaline phosphatase,in patients with ovarian carcinoma,borderline tumors,or benign adnexal masses:relevance for differential diagnosis显示文摘 | Tholander B Taube A Lindgren A | 1990 | Gynecol On-col1990，39，： | 1 |
| 6 | In vitro hydrolysis rate and protein binding of clevidipine, a new uhrashor- tactingcalcium antagonist metabolisedby esterases, in different animal species and man显示文摘 | ERICSSON H THOLANDER B REGARDH CG | 1999 | Eur J Pharm Sci1999，8，1： | 1 |
| 7 | Pharrnacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs 显示文摘 | Ericsson H Tholander B Bj 6rkman JA | 1999 | Drug Metab Dispos1999，27，： | 1 |
| 8 | Pretreatment serum levels of CA 125,carcinoembryoic antigen,tissue polypeptide antigen,and placental alkaline phosphatase in patients with ovarian carcinoma:influence of histological type,grade of differentiation,and clinical stage of disease显示文摘 | Tholander B Taube A Lindgren A | 1990 | Gynecol Oncol1990，39，3： | 1 |
| 9 | Efficacy and safety results from OCTAVIA, a single-arm phase Ⅱ study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer显示文摘 | Gonzalez-Martina A Gladieff L Tholander B | 2013 | Eur J Cancer2013，49，18： | 1 |
| 10 | Pretreatment serum levels of CA-125,carcinoembryonic antigen,tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease显示文摘 | Tholander B Taube A Lindgren A | 1990 | Gynecol Oncol1990，39，1： | 1 |
| 11 | Pretreatment serum leveals of CA125 carcinoembryonic antigen, tissue polypetide antigen and placental alkalive phosphatate, in patients with ovarian carcinoma borderline tumers, or benign adnexalmasses relevance for differential diagnosis显示文摘 | Tholander B Taube A Lindgren A | 1990 | Gynecol Oncol1990，39，1： | 1 |
| 12 | Paralysis of nematodes:shifts in the transcriptome of the nematode- trapping fungus Monacrosporium haptotylum during in- fection of Caenorhabditls elegans显示文摘 | Fekete C Tholander M Rajashekar B | 2008 | Environ Microbiol2008，10，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员